共价抑制剂与表观遗传学相遇:新的机遇
Qiang Feng1, Luoting Yu2, Lu Li3
1College of Chemistry and Life Science, Sichuan Provincial Key Laboratory for Structural Optimization and Application of Functional Molecules, Chengdu Normal University, Chengdu, 611130, China.
European journal of medicinal chemistry
|October 15, 2024
概括
共价抑制剂为表观遗传药物提供了新的希望,克服了当前治疗方法的局限性. 本综述探讨了40多种性抑制剂,针对29种表观遗传调节剂,突出了它们在疾病治疗中提高疗效和降低毒性的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 表观遗传干预对于治疗癌症等疾病至关重要.
- 目前的表观遗传药物面临的挑战包括低效率,毒性和耐药性.
- 协同抑制剂正在成为解决这些局限性的有希望的策略.
研究的目的:
- 审查针对表观遗传调节者的共价抑制剂的设计,机制和应用.
- 探索共价表观遗传药物在克服当前治疗挑战方面的潜力.
- 确定开发先进的共价表观遗传抑制剂的新机会.
主要方法:
- 针对表观遗传调节器的共价抑制剂的综合文献搜索.
- 对设计策略,反应机制和共价弹头的分析.
- 针对性氨基酸和共价验证方法的评估.
主要成果:
- 确定和分析了40多种向29个不同的表观遗传向的共价抑制剂.
- 详细检查共价核弹头,向氨基酸和反应机制.
- 讨论缓慢分离动力学和改进的对象参与的共价抑制剂.
结论:
- 共价抑制剂代表了表观遗传药物开发的重大进步.
- 这些抑制剂显示出增强疗效,选择性和克服耐药性的潜力.
- 预计对共价表观遗传抑制剂的进一步开发将产生重大治疗突破.
相关概念视频
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Co-activators and Co-repressors
2.3K
2.3K
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Histone Modification
13.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.1K


